510(k) Report

PMA · Approved

Approved

Brava CRT-D, Brava Quad CRT-D, Viva Quad S CRT-D, Viva Quad XT CRT-D, Viva S CRT-D, Viva XT CRT-D

P010031/S511PMAApproved Oct 29, 201555-day reviewClass III21 CFR 870.3700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medtronic Cardiac Rhythm Disease Management · KRG Programmer, Pacemaker

Approved on Oct 29, 2015 through premarket approval, which rests on the device’s own clinical evidence after a 55-day review.

Decided
Oct 29, 2015
Review
55 days
Class
Class III
Product code
KRG
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

FIG. 1 — Lineage of P010031/S511Source: FDA PMA database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All KRG devices

KRG Programmer, Pacemaker: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · KRG

2in 2015

2013: 12014: 12015: 2
2007high 2 (2015) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRG

Too few KRG 510(k)s in any year since 2007 to give a median.

Recalls per year · KRG

2in 2016

2010: 22016: 2
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KRG

810in 2025

2007: 202008: 112009: 142010: 262011: 7312012: 1,4882013: 1,3772014: 2,5412015: 3,2442016: 1,8862017: 1,4072018: 1,3262019: 1,1742020: 1,6892021: 1,7002022: 1,3592023: 1,0692024: 1,5452025: 810
2007high 3,244 (2015) · low 11 (2008)2025

MAUDE reports naming product code KRG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—020
20080—011
20090—014
20100—226
20110—0731
20120—01,488
20131—01,377
20141—02,541
20152—03,244
20160—21,886
20170—01,407
20180—01,326
20190—01,174
20200—01,689
20210—01,700
20220—01,359
20230—01,069
20240—01,545
20250—0810
20260—0—
Cite this page

510(k) Report. “P010031/S511: Brava CRT-D, Brava Quad CRT-D, Viva Quad S CRT-D, Viva Quad XT CRT-D, Viva S CRT-D, Viva XT CRT-D.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/P010031/S511

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026